Most Recent
Former PwC partner settles defamation claim over tax leaks statements
A former PricewaterhouseCoopers partner has settled his defamation claim against the firm over public statements that allegedly falsely linked him to its tax leaks scandal in 2023.
Class actions against Ford, Toyota score major win in High Court
The High Court has upheld appeals in class actions against Ford and Toyota over the calculation of damages for reduction in value of defective vehicles.
$405M pelvic mesh settlement distribution can’t ‘drag on’, judge says
A judge has expressed concerns after hearing that up to 20,000 group members in three pelvic mesh class actions have yet to receive payment from $405 million in settlements approved in March last year.
‘Highly irresponsible’: Peninsula Health must pay $316,000 in junior doctors class action
A judge has ordered Victoria's Peninsula Health to fork over $316,260 in penalties for failing to pay overtime to a junior doctor leading a class action, saying the hospital operator had a “highly irresponsible attitude”.
INPEX can cross-examine AkzoNobel’s lawyers over ‘inadequate’ discovery
INPEX has won a bid to cross-examine AkzoNobel's solicitors about discovery at the end of an 11-week trial over allegedly defective paint used on the $45 billion Ichthys natural gas project. 
At last minute, Care A2 finds law firm to replace Ashurst in IP spat
Infant formula company Care A2 has found new lawyers as trial begins in a trade mark dispute with rival a2 Milk.
WiseTech’s Richard White resolves legal spat with beautician
A Sydney beautician has resolved her action seeking to set aside a bankruptcy notice filed by her alleged former lover, WiseTech Global boss Richard White.
Ditched by Ashurst, Care A2 set to miss own trade mark trial
Care A2 is set to miss the trial in its trade mark fight with rival A2 Milk after the baby formula company was ditched by its lawyers at Ashurst days ago. 
New battle in Lexapro patent war between Lundbeck, Sandoz
Novartis unit Sandoz is appealing a tribunal decision in favour of pharmaceutical company Lundbeck over a licence to sell a generic version of leading antidepressant Lexapro.